Lv3
320 积分 2025-05-20 加入
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
15天前
已完结
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
22天前
已关闭
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
29天前
已完结
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
30天前
已关闭
Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma
1个月前
已完结
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
1个月前
已关闭
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
1个月前
已关闭
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma
1个月前
已关闭
A guide to antigen processing and presentation
1个月前
已完结
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
1个月前
已完结
皖公网安备34019202002308
